| LIR LIFE SCIENCES CORP. |
| Kanada |
| Gesundheit |
| CA50206C1005 / A41QA9 |
| N790 (Frankfurt) |
| FRA:N790, ETR:N790, N790:GR |
| - |
| - |
|
LIR Life Sciences Corp. is a biopharmaceutical company focused on developing innovative transdermal and sublingual drug delivery systems, particularly targeting obesity and metabolic disorders. Founded in 2024 and headquartered in Vancouver, Canada, ..
>Volltext.. |
| 8.15 Mio. EUR |
| 7.24 Mio. EUR |
| - |
| -0.28 Mio. EUR |
| -4.23 Mio. EUR |
| -0.86 EUR |
| - |
| - |
| -0.09 Mio. EUR |
| 26.99 |
| - |
| -153.03% |
| - |
| - |
| - |
| - |
| LIR LIFE SCIENCES, LIR LIFE |
| 04.04.26 |